Wnt10b activates the wnt, notch, and NFIκB pathways in u2os osteosarcoma cells

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Although osteosarcoma represents the most common bone malignancy, the molecular and cellular mechanisms influencing its pathogenesis have remained elusive. Recent evidence has suggested that the Wnt signaling pathway may play a crucial role in osteosarcoma. This study employed a microarray approach to discover novel genes and pathways involved in Wnt signaling in osteosarcoma. We developed a Wnt10b-expressing cell line using the human U2OS osteosarcoma model (U2OS-Wnt10b) and performed microarray and pathway analyses using parental U2OS cells as control. Differential expression of 1,003 genes encompassing 28 pathways was noted. The Wnt, NFIκB, and Notch pathways were chosen for further study based on their known importance in bone biology. Known Wnt-responsive genes Axin-2 (4.9-fold), CD44 (2.1-fold), endothelin-1 (4.2-fold) and sclerostin domain containing-1 (43-fold) were regulated by Wnt10b. The proinflammatory cytokines interleukin-1α and tumor necrosis factor-α, known inducers of NFIκB, were upregulated both at the transcript and protein level, and NFIκB reporter activity was stimulated 3.8-fold, confirming NFIκB activation. Interestingly, genes involved in Notch signaling [Notch-1 (2.4-fold) and Jagged-1 (3.1-fold)] were upregulated, whereas the Notch inhibitor, lunatic fringe, was downregulated (8.2-fold). This resulted in the activation of the classic Notch-responsive genes, hairy and enhancer of split-1 (Hes-1; 2.2-fold) and hairy/enhancer-of-split related with YRPW motif-1 (Hey-1; 2.5-fold). A Hey-1 reporter construct was regulated 9.1-fold in U2OS-Wnt10b cells, confirming Notch activation. Interestingly, Wnt3a failed to induce the Notch and NFIκB pathways, demonstrating Wnt-specificity. In conclusion, our data demonstrate that Wnt10b, but not Wnt3a, stimulates the NFIκB and Notch pathways in U2OS osteosarcoma cells.

Original languageEnglish (US)
Pages (from-to)1392-1402
Number of pages11
JournalJournal of Cellular Biochemistry
Volume112
Issue number5
DOIs
StatePublished - May 2011

Fingerprint

Osteosarcoma
Genes
Wnt Signaling Pathway
Chemical activation
Microarrays
Bone
Bone and Bones
Endothelin-1
Microarray Analysis
Interleukin-1
Down-Regulation
Tumor Necrosis Factor-alpha
Cells
Cytokines
Cell Line
Neoplasms
Proteins

Keywords

  • bone
  • microarray
  • notch
  • osteosarcoma
  • Wnt10b

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Molecular Biology

Cite this

Wnt10b activates the wnt, notch, and NFIκB pathways in u2os osteosarcoma cells. / Mödder, Ulrike I.; Oursler, Merry Jo; Khosla, Sundeep; Monroe, David G.

In: Journal of Cellular Biochemistry, Vol. 112, No. 5, 05.2011, p. 1392-1402.

Research output: Contribution to journalArticle

@article{6edb4335fd264f6aba126d0531f9acab,
title = "Wnt10b activates the wnt, notch, and NFIκB pathways in u2os osteosarcoma cells",
abstract = "Although osteosarcoma represents the most common bone malignancy, the molecular and cellular mechanisms influencing its pathogenesis have remained elusive. Recent evidence has suggested that the Wnt signaling pathway may play a crucial role in osteosarcoma. This study employed a microarray approach to discover novel genes and pathways involved in Wnt signaling in osteosarcoma. We developed a Wnt10b-expressing cell line using the human U2OS osteosarcoma model (U2OS-Wnt10b) and performed microarray and pathway analyses using parental U2OS cells as control. Differential expression of 1,003 genes encompassing 28 pathways was noted. The Wnt, NFIκB, and Notch pathways were chosen for further study based on their known importance in bone biology. Known Wnt-responsive genes Axin-2 (4.9-fold), CD44 (2.1-fold), endothelin-1 (4.2-fold) and sclerostin domain containing-1 (43-fold) were regulated by Wnt10b. The proinflammatory cytokines interleukin-1α and tumor necrosis factor-α, known inducers of NFIκB, were upregulated both at the transcript and protein level, and NFIκB reporter activity was stimulated 3.8-fold, confirming NFIκB activation. Interestingly, genes involved in Notch signaling [Notch-1 (2.4-fold) and Jagged-1 (3.1-fold)] were upregulated, whereas the Notch inhibitor, lunatic fringe, was downregulated (8.2-fold). This resulted in the activation of the classic Notch-responsive genes, hairy and enhancer of split-1 (Hes-1; 2.2-fold) and hairy/enhancer-of-split related with YRPW motif-1 (Hey-1; 2.5-fold). A Hey-1 reporter construct was regulated 9.1-fold in U2OS-Wnt10b cells, confirming Notch activation. Interestingly, Wnt3a failed to induce the Notch and NFIκB pathways, demonstrating Wnt-specificity. In conclusion, our data demonstrate that Wnt10b, but not Wnt3a, stimulates the NFIκB and Notch pathways in U2OS osteosarcoma cells.",
keywords = "bone, microarray, notch, osteosarcoma, Wnt10b",
author = "M{\"o}dder, {Ulrike I.} and Oursler, {Merry Jo} and Sundeep Khosla and Monroe, {David G}",
year = "2011",
month = "5",
doi = "10.1002/jcb.23048",
language = "English (US)",
volume = "112",
pages = "1392--1402",
journal = "Journal of Cellular Biochemistry",
issn = "0730-2312",
publisher = "Wiley-Liss Inc.",
number = "5",

}

TY - JOUR

T1 - Wnt10b activates the wnt, notch, and NFIκB pathways in u2os osteosarcoma cells

AU - Mödder, Ulrike I.

AU - Oursler, Merry Jo

AU - Khosla, Sundeep

AU - Monroe, David G

PY - 2011/5

Y1 - 2011/5

N2 - Although osteosarcoma represents the most common bone malignancy, the molecular and cellular mechanisms influencing its pathogenesis have remained elusive. Recent evidence has suggested that the Wnt signaling pathway may play a crucial role in osteosarcoma. This study employed a microarray approach to discover novel genes and pathways involved in Wnt signaling in osteosarcoma. We developed a Wnt10b-expressing cell line using the human U2OS osteosarcoma model (U2OS-Wnt10b) and performed microarray and pathway analyses using parental U2OS cells as control. Differential expression of 1,003 genes encompassing 28 pathways was noted. The Wnt, NFIκB, and Notch pathways were chosen for further study based on their known importance in bone biology. Known Wnt-responsive genes Axin-2 (4.9-fold), CD44 (2.1-fold), endothelin-1 (4.2-fold) and sclerostin domain containing-1 (43-fold) were regulated by Wnt10b. The proinflammatory cytokines interleukin-1α and tumor necrosis factor-α, known inducers of NFIκB, were upregulated both at the transcript and protein level, and NFIκB reporter activity was stimulated 3.8-fold, confirming NFIκB activation. Interestingly, genes involved in Notch signaling [Notch-1 (2.4-fold) and Jagged-1 (3.1-fold)] were upregulated, whereas the Notch inhibitor, lunatic fringe, was downregulated (8.2-fold). This resulted in the activation of the classic Notch-responsive genes, hairy and enhancer of split-1 (Hes-1; 2.2-fold) and hairy/enhancer-of-split related with YRPW motif-1 (Hey-1; 2.5-fold). A Hey-1 reporter construct was regulated 9.1-fold in U2OS-Wnt10b cells, confirming Notch activation. Interestingly, Wnt3a failed to induce the Notch and NFIκB pathways, demonstrating Wnt-specificity. In conclusion, our data demonstrate that Wnt10b, but not Wnt3a, stimulates the NFIκB and Notch pathways in U2OS osteosarcoma cells.

AB - Although osteosarcoma represents the most common bone malignancy, the molecular and cellular mechanisms influencing its pathogenesis have remained elusive. Recent evidence has suggested that the Wnt signaling pathway may play a crucial role in osteosarcoma. This study employed a microarray approach to discover novel genes and pathways involved in Wnt signaling in osteosarcoma. We developed a Wnt10b-expressing cell line using the human U2OS osteosarcoma model (U2OS-Wnt10b) and performed microarray and pathway analyses using parental U2OS cells as control. Differential expression of 1,003 genes encompassing 28 pathways was noted. The Wnt, NFIκB, and Notch pathways were chosen for further study based on their known importance in bone biology. Known Wnt-responsive genes Axin-2 (4.9-fold), CD44 (2.1-fold), endothelin-1 (4.2-fold) and sclerostin domain containing-1 (43-fold) were regulated by Wnt10b. The proinflammatory cytokines interleukin-1α and tumor necrosis factor-α, known inducers of NFIκB, were upregulated both at the transcript and protein level, and NFIκB reporter activity was stimulated 3.8-fold, confirming NFIκB activation. Interestingly, genes involved in Notch signaling [Notch-1 (2.4-fold) and Jagged-1 (3.1-fold)] were upregulated, whereas the Notch inhibitor, lunatic fringe, was downregulated (8.2-fold). This resulted in the activation of the classic Notch-responsive genes, hairy and enhancer of split-1 (Hes-1; 2.2-fold) and hairy/enhancer-of-split related with YRPW motif-1 (Hey-1; 2.5-fold). A Hey-1 reporter construct was regulated 9.1-fold in U2OS-Wnt10b cells, confirming Notch activation. Interestingly, Wnt3a failed to induce the Notch and NFIκB pathways, demonstrating Wnt-specificity. In conclusion, our data demonstrate that Wnt10b, but not Wnt3a, stimulates the NFIκB and Notch pathways in U2OS osteosarcoma cells.

KW - bone

KW - microarray

KW - notch

KW - osteosarcoma

KW - Wnt10b

UR - http://www.scopus.com/inward/record.url?scp=79953711145&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953711145&partnerID=8YFLogxK

U2 - 10.1002/jcb.23048

DO - 10.1002/jcb.23048

M3 - Article

C2 - 21321991

AN - SCOPUS:79953711145

VL - 112

SP - 1392

EP - 1402

JO - Journal of Cellular Biochemistry

JF - Journal of Cellular Biochemistry

SN - 0730-2312

IS - 5

ER -